Disclosures for "Interpreting Adverse Events of Somnolence With Lemborexant in Clinical Trials"
-
Margaret Moline has received personal compensation for serving as an employee of EISAI, INC.. Margaret Moline has received intellectual property interests from a discovery or technology relating to health care. Margaret Moline has received personal compensation in the range of $0-$499 for serving as a review, loan repayment program with NIH.
-
Dr. Réaume has received personal compensation for serving as an employee of Eisai.
-
Dinesh Kumar has received personal compensation for serving as an employee of Eisai Inc.
-
Mrs. Pinner has received personal compensation for serving as an employee of Eisai Ltd..
-
Dr. Swainson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for abbvie. Dr. Swainson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Swainson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Dr. Swainson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Idorsia. Dr. Swainson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novonordisk. Dr. Swainson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch. Dr. Swainson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Swainson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Elvium. Dr. Swainson has received personal compensation in the range of $500-$4,999 for serving as a advisor with College of Physicians and Surgeons of Alberta.